Non-alcoholic fatty liver disease surgery

Revision as of 04:17, 18 December 2017 by Gunnam (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

Non-Alcoholic Fatty Liver Disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Non-alcoholic fatty liver disease surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-alcoholic fatty liver disease surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-alcoholic fatty liver disease surgery

CDC on Non-alcoholic fatty liver disease surgery

Non-alcoholic fatty liver disease surgery in the news

Blogs on Non-alcoholic fatty liver disease surgery

Directions to Hospitals Treating Non-alcoholic fatty liver disease

Risk calculators and risk factors for Non-alcoholic fatty liver disease surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Surgery is not the first-line treatment option for patients with NAFLD.The mainstay of treatment for NAFLD is medical therapy and weight loss.

Surgery

  • Given the importance of weight loss, the outcomes of bariatric surgical procedure at the natural records of NAFLD were pronounced with the aid of numerous groups.[1]
  • Meta-analyses show that diverse bariatric surgical modalities yielding loss of 20% to 40% of baseline BMI bring about substantial histologic development.
  • Few sufferers enjoy entire resolution of NASH.
  • Bariatric surgery is associated with a massive improvement in each histological and biochemical markers of NAFLD.[2]
  • Further studies is needed to understand the precise mechanisms and future studies have to focus on better tiers of proof to higher pick out the advantages of bariatric surgical operation on liver disease so one can enhance destiny treatment strategies within the management of NAFLD.

References

  1. Sukhanova NN (1989). "[Somatotypes in evaluating the physical development of 11-year-old schoolchildren]". Gig Sanit (in Russian) (9): 84–6. PMID 2591798.
  2. Vizuete J, Camero A, Malakouti M, Garapati K, Gutierrez J (2017). "Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies". J Clin Transl Hepatol. 5 (1): 67–75. doi:10.14218/JCTH.2016.00061. PMC 5411359. PMID 28507929.

Template:WS Template:WH